A new study from Greece confirms the long-suspected connection between migraines and psychiatric comorbidities such as depression, anxiety disorders and sleep disorders. As the frequency of migraine attacks increases, the risk of these additional illnesses increases significantly. The President of the Austrian Headache Society, Dr. Sonja-Maria Tesar, emphasizes the importance of early diagnosis and effective treatment of migraines in order to prevent the development and worsening of these psychiatric comorbidities.
Around 13% of the population worldwide suffers from migraines, with women being affected up to three times more often than men. In Austria, this is more than a million people. Studies show that migraines not only severely impair quality of life, but also increase the risk of psychiatric disorders.
An Austrian study found that almost two thirds of migraine patients also suffer from anxiety disorders and depression. Similar results were found in studies from Spain, the USA and the most recent Greek study. In particular, the new migraine prophylactics, special monoclonal antibodies, not only show an effect against migraine attacks themselves, but also a positive influence on psychiatric symptoms.
Modern migraine therapy is increasingly focusing on these new prophylactics, which specifically intervene in the mechanisms of migraine and are very well tolerated. They not only reduce the number of headache days, but also show effects on the associated psychiatric disorders.
and 